---
layout: default
title: Patient-specific Biomolecular Instruction Tuning
---

# Patient-specific Biomolecular Instruction Tuning

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2509.22853" class="toolbar-btn" target="_blank">üìÑ arXiv: 2509.22853v1</a>
  <a href="https://arxiv.org/pdf/2509.22853.pdf" class="toolbar-btn" target="_blank">üì• PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2509.22853v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2509.22853v1', 'Patient-specific Biomolecular Instruction Tuning')" title="Ê∑ªÂä†Âà∞Êî∂ËóèÂ§π">‚òÜ Êî∂Ëóè</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">üîó ÂàÜ‰∫´</button>
</div>


**‰ΩúËÄÖ**: Irsyad Adam, Zekai Chen, David Laub, Shaun Porwal, Arda Pekis, Kevin Brown

**ÂàÜÁ±ª**: q-bio.QM, cs.AI, cs.CL, cs.LG

**ÂèëÂ∏ÉÊó•Êúü**: 2025-09-26

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**ÊèêÂá∫KRONOSÂõæ-LLMÊ°ÜÊû∂ÔºåÁªìÂêàCPTAC-PROTSTRUCTÊï∞ÊçÆÈõÜÔºåÊèêÂçáËÇøÁò§Á≤æÂáÜÂåªÁñó‰∏≠ÊÇ£ËÄÖ‰∏™‰ΩìÂåñËõãÁôΩË¥®ÁªÑÂ≠¶ÁêÜËß£„ÄÇ**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰πùÔºöÂÖ∑Ë∫´Â§ßÊ®°Âûã (Embodied Foundation Models)**

**ÂÖ≥ÈîÆËØç**: `ËõãÁôΩË¥®ÁªÑÂ≠¶` `Â§ßÂûãËØ≠Ë®ÄÊ®°Âûã` `ÂõæÁ•ûÁªèÁΩëÁªú` `Êåá‰ª§Ë∞É‰ºò` `Á≤æÂáÜÂåªÁñó`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Áé∞ÊúâÊñπÊ≥ïÁº∫‰πè‰ªéËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆËøõË°å‰∏¥Â∫äËß£ÈáäÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºåÈôêÂà∂‰∫ÜLLMÂú®ËÇøÁò§Á≤æÂáÜÂåªÁñó‰∏≠ÁöÑÂ∫îÁî®„ÄÇ
2. KRONOSÊ°ÜÊû∂ÁªìÂêàÂàÜÂ≠êÁõ∏‰∫í‰ΩúÁî®ÊãìÊâëÁªìÊûÑ‰∏éËõãÁôΩË¥®ÁªÑÂ≠¶ÔºåÂ≠¶‰π†ÊÇ£ËÄÖÁâπÂÆöÁöÑÂõæË°®Á§∫ÔºåÂ¢ûÂº∫LLMÁöÑ‰∏¥Â∫äÊé®ÁêÜËÉΩÂäõ„ÄÇ
3. ÂÆûÈ™åÁªìÊûúË°®ÊòéÔºåKRONOSÂú®ÂàÜÂ≠êÂàÜÁ±ª„ÄÅÊó∂Èó¥ËΩ®ËøπÂª∫Ê®°ÂíåËÇøÁò§ÂàÜÊúüÈ¢ÑÊµãÁ≠â‰ªªÂä°‰∏≠Ë°®Áé∞Âá∫Ëâ≤ÔºåÊèêÂçá‰∫ÜÁ≤æÂáÜÂåªÁñóÊ∞¥Âπ≥„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆÂØπ‰∫éÁêÜËß£ÁñæÁóÖÁöÑËá¥ÁóÖÊú∫Âà∂Ëá≥ÂÖ≥ÈáçË¶Å„ÄÇÂú®ÁôåÁóáÁ†îÁ©∂‰∏≠ÔºåÂàÜÂ≠êÁâπÂæÅÂàÜÊûêËÉΩÂ§üÈÄöËøáËØÜÂà´È©±Âä®‰∏™‰ΩìÂåñËÇøÁò§ËøõÂ±ï„ÄÅÊ≤ªÁñóÊäµÊäóÂíå‰∏¥Â∫äÂºÇË¥®ÊÄßÁöÑÁîüÁâ©ËøáÁ®ãÔºåÂÆûÁé∞Á≤æÂáÜÂåªÁñó„ÄÇÂ§öÊ®°ÊÄÅÂ§ßÂûãËØ≠Ë®ÄÊ®°ÂûãÔºàLLMsÔºâÁöÑÊúÄÊñ∞ËøõÂ±ïÂ±ïÁé∞‰∫ÜÊï¥ÂêàÂíåÊé®ÁêÜÂºÇÊûÑÊï∞ÊçÆÁöÑÂçìË∂äËÉΩÂäõ„ÄÇÁÑ∂ËÄåÔºåÁî±‰∫éÁº∫‰πèËÉΩÂ§ü‰ªéËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆËøõË°å‰∏¥Â∫äËß£ÈáäÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºå‰ª•ÂèäÁº∫‰πèÊó®Âú®ÊçïËé∑ÂàÜÂ≠êÊï∞ÊçÆ‰∏∞ÂØåÂºÇË¥®ÊÄßÁöÑËØ≠Ë®ÄÂª∫Ê®°Êû∂ÊûÑÔºåÂõ†Ê≠§ÂØπÊÇ£ËÄÖÁâπÂÆöËõãÁôΩË¥®ÁªÑÂ≠¶ËøõË°åÂ§öÊ®°ÊÄÅËØ≠Ë®ÄÂª∫Ê®°‰ªçÁÑ∂ÊòØ‰∏Ä‰∏™ÈáçÂ§ßÊåëÊàò„ÄÇÊú¨ÊñáÊèêÂá∫‰∫ÜCPTAC-PROTSTRUCTÔºåËøôÊòØÈ¶ñ‰∏™Áî®‰∫éËÇøÁò§ÂàÜÂ≠êÁêÜËß£ÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºåÂåÖÂê´Ë∂ÖËøá40‰∏á‰∏™ÂºÄÊîæÂºèÁ§∫‰æãÔºåËøô‰∫õÁ§∫‰æãÊù•Ê∫ê‰∫éÂõΩÂÆ∂ËõãÁôΩË¥®ÁªÑÂ≠¶ÁôåÁóáÁ†îÁ©∂ÔºàCPTACÔºâ‰∏≠‰∏™‰ΩìÂåñÁöÑËõãÁôΩË¥®ÁªÑÂ≠¶Ë∞±„ÄÇÊ≠§Â§ñÔºåÊàë‰ª¨ÊèêÂá∫‰∫ÜKRONOSÔºàÈÄöËøáÁªìÊûÑÂåñË∞É‰ºòÂÆûÁé∞ËÇøÁò§ÊÇ£ËÄÖÁªÑÂ≠¶ÁΩëÁªúÁü•ËØÜË°®Á§∫ÔºâÔºåËøôÊòØ‰∏Ä‰∏™Êñ∞È¢ñÁöÑÂõæ-LLMÊ°ÜÊû∂ÔºåÂÆÉÂà©Áî®ÂàÜÂ≠êÁõ∏‰∫í‰ΩúÁî®ÊãìÊâëÁªìÊûÑ‰∏éËõãÁôΩË¥®ÁªÑÂ≠¶Êù•Â≠¶‰π†ÊÇ£ËÄÖÁâπÂÆöÁöÑÂõæË°®Á§∫Ôºå‰ª•Â¢ûÂº∫‰∏¥Â∫äÊé®ÁêÜËÉΩÂäõ„ÄÇÂÆûÈ™åË°®ÊòéÔºåKRONOSÂú®Âü∫ÂáÜ‰∏¥Â∫ä‰ªªÂä°ÔºàÂåÖÊã¨ÂàÜÂ≠êÂàÜÁ±ª„ÄÅÊó∂Èó¥ËΩ®ËøπÂª∫Ê®°ÂíåËõãÁôΩË¥®ÁªÑÂ≠¶ËÇøÁò§ÂàÜÊúüÈ¢ÑÊµãÔºâ‰∏≠ÂèñÂæó‰∫ÜÂÖ∑ÊúâÁ´û‰∫âÂäõÁöÑÊÄßËÉΩ„ÄÇÊúÄÁªàÔºåËøôÁßçÊñπÊ≥ï‰ΩøLLMËÉΩÂ§üÁêÜËß£ÊÇ£ËÄÖÂ±ÇÈù¢ÁöÑÂèëÁóÖÊú∫Âà∂ÔºåÈÄöËøáÊõ¥ÂáÜÁ°ÆÁöÑËØäÊñ≠„ÄÅÈ¢ÑÂêéÂíåÊ≤ªÁñóÂàÜÂ±ÇÊù•Êé®ËøõÁ≤æÂáÜÂåªÁñó„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöËÆ∫ÊñáÊó®Âú®Ëß£ÂÜ≥Â§ßÂûãËØ≠Ë®ÄÊ®°ÂûãÔºàLLMsÔºâÂú®ÁêÜËß£ÊÇ£ËÄÖÁâπÂÆöËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆÔºåÂπ∂Â∞ÜÂÖ∂Â∫îÁî®‰∫éËÇøÁò§Á≤æÂáÜÂåªÁñóÊó∂Èù¢‰∏¥ÁöÑ‰∏§‰∏™‰∏ªË¶ÅÈóÆÈ¢òÔºö‰∏ÄÊòØÁº∫‰πèÂêàÈÄÇÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºå‰∫åÊòØÁº∫‰πèËÉΩÂ§üÊúâÊïàÂ§ÑÁêÜÂàÜÂ≠êÊï∞ÊçÆÂºÇË¥®ÊÄßÁöÑËØ≠Ë®ÄÂª∫Ê®°Êû∂ÊûÑ„ÄÇÁé∞ÊúâÊñπÊ≥ïÈöæ‰ª•ÂÖÖÂàÜÂà©Áî®ËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆ‰∏≠ÁöÑ‰ø°ÊÅØÔºåÈôêÂà∂‰∫ÜLLMsÂú®‰∏¥Â∫äËØäÊñ≠„ÄÅÈ¢ÑÂêéÂíåÊ≤ªÁñóÂàÜÂ±ÇÊñπÈù¢ÁöÑÂ∫îÁî®„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöËÆ∫ÊñáÁöÑÊ†∏ÂøÉÊÄùË∑ØÊòØÊûÑÂª∫‰∏Ä‰∏™Â§ßËßÑÊ®°ÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºàCPTAC-PROTSTRUCTÔºâÔºåÂπ∂ËÆæËÆ°‰∏Ä‰∏™Âõæ-LLMÊ°ÜÊû∂ÔºàKRONOSÔºâÔºåÂ∞ÜËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆ‰∏éÂàÜÂ≠êÁõ∏‰∫í‰ΩúÁî®ÁΩëÁªúÁõ∏ÁªìÂêàÔºå‰ªéËÄå‰ΩøLLMsËÉΩÂ§üÊõ¥Â•ΩÂú∞ÁêÜËß£ÊÇ£ËÄÖÂ±ÇÈù¢ÁöÑÂèëÁóÖÊú∫Âà∂ÔºåÂπ∂ËøõË°åÊõ¥ÂáÜÁ°ÆÁöÑ‰∏¥Â∫äÊé®ÁêÜ„ÄÇÈÄöËøáÊåá‰ª§Ë∞É‰ºòÔºåLLMÂèØ‰ª•Â≠¶‰π†Â¶Ç‰Ωï‰ªéËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆ‰∏≠ÊèêÂèñÊúâÁî®ÁöÑ‰∏¥Â∫ä‰ø°ÊÅØ„ÄÇÈÄöËøáÂõæÁªìÊûÑÔºåLLMÂèØ‰ª•Êõ¥Â•ΩÂú∞ÁêÜËß£ÂàÜÂ≠ê‰πãÈó¥ÁöÑÁõ∏‰∫í‰ΩúÁî®ÂÖ≥Á≥ª„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöKRONOSÊ°ÜÊû∂ÂåÖÂê´‰ª•‰∏ã‰∏ªË¶ÅÊ®°ÂùóÔºö1) Êï∞ÊçÆÈ¢ÑÂ§ÑÁêÜÊ®°ÂùóÔºåÁî®‰∫éÂ§ÑÁêÜËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆÂíåÂàÜÂ≠êÁõ∏‰∫í‰ΩúÁî®ÁΩëÁªúÊï∞ÊçÆÔºõ2) ÂõæË°®Á§∫Â≠¶‰π†Ê®°ÂùóÔºåÁî®‰∫éÂ≠¶‰π†ÊÇ£ËÄÖÁâπÂÆöÁöÑÂõæË°®Á§∫Ôºõ3) LLMÊé®ÁêÜÊ®°ÂùóÔºåÁî®‰∫éÂü∫‰∫éÂõæË°®Á§∫ËøõË°å‰∏¥Â∫äÊé®ÁêÜÔºå‰æãÂ¶ÇÂàÜÂ≠êÂàÜÁ±ª„ÄÅÊó∂Èó¥ËΩ®ËøπÂª∫Ê®°ÂíåËÇøÁò§ÂàÜÊúüÈ¢ÑÊµã„ÄÇCPTAC-PROTSTRUCTÊï∞ÊçÆÈõÜÁî®‰∫éÊåá‰ª§Ë∞É‰ºòLLMÔºå‰ΩøÂÖ∂ËÉΩÂ§üÊõ¥Â•ΩÂú∞ÁêÜËß£ËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆ„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöËÆ∫ÊñáÁöÑÂÖ≥ÈîÆÂàõÊñ∞ÁÇπÂú®‰∫éÔºö1) ÊèêÂá∫‰∫ÜCPTAC-PROTSTRUCTÊï∞ÊçÆÈõÜÔºåËøôÊòØÈ¶ñ‰∏™Áî®‰∫éËÇøÁò§ÂàÜÂ≠êÁêÜËß£ÁöÑÊåá‰ª§Ë∞É‰ºòÊï∞ÊçÆÈõÜÔºõ2) ÊèêÂá∫‰∫ÜKRONOSÊ°ÜÊû∂ÔºåËØ•Ê°ÜÊû∂Â∞ÜÂõæÁ•ûÁªèÁΩëÁªú‰∏éLLMÁõ∏ÁªìÂêàÔºåËÉΩÂ§üÊõ¥Â•ΩÂú∞Â§ÑÁêÜÂàÜÂ≠êÊï∞ÊçÆÁöÑÂºÇË¥®ÊÄßÔºåÂπ∂ËøõË°åÊõ¥ÂáÜÁ°ÆÁöÑ‰∏¥Â∫äÊé®ÁêÜ„ÄÇ‰∏éÁé∞ÊúâÊñπÊ≥ïÁõ∏ÊØîÔºåKRONOSËÉΩÂ§üÊõ¥Â•ΩÂú∞Âà©Áî®ËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆ‰∏≠ÁöÑ‰ø°ÊÅØÔºåÂπ∂ËøõË°åÊõ¥ÂáÜÁ°ÆÁöÑ‰∏¥Â∫äÈ¢ÑÊµã„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöKRONOSÊ°ÜÊû∂‰ΩøÁî®ÂõæÁ•ûÁªèÁΩëÁªúÔºàGNNÔºâÊù•Â≠¶‰π†ÊÇ£ËÄÖÁâπÂÆöÁöÑÂõæË°®Á§∫„ÄÇGNNÁöÑÁªìÊûÑÂíåÂèÇÊï∞ÈúÄË¶ÅÊ†πÊçÆÂÖ∑‰Ωì‰ªªÂä°ËøõË°åË∞ÉÊï¥„ÄÇLLMÂèØ‰ª•‰ΩøÁî®È¢ÑËÆ≠ÁªÉÁöÑËØ≠Ë®ÄÊ®°ÂûãÔºå‰æãÂ¶ÇBERTÊàñGPT„ÄÇÊçüÂ§±ÂáΩÊï∞ÂèØ‰ª•‰ΩøÁî®‰∫§ÂèâÁÜµÊçüÂ§±ÊàñÂùáÊñπËØØÂ∑ÆÊçüÂ§±„ÄÇÊåá‰ª§Ë∞É‰ºòËøáÁ®ãÈúÄË¶Å‰ªîÁªÜËÆæËÆ°Êåá‰ª§Ôºå‰ª•Á°Æ‰øùLLMËÉΩÂ§üÂ≠¶‰π†Âà∞ÊúâÁî®ÁöÑ‰∏¥Â∫ä‰ø°ÊÅØ„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

KRONOSÂú®ÂàÜÂ≠êÂàÜÁ±ª„ÄÅÊó∂Èó¥ËΩ®ËøπÂª∫Ê®°ÂíåËÇøÁò§ÂàÜÊúüÈ¢ÑÊµãÁ≠âÂü∫ÂáÜ‰∏¥Â∫ä‰ªªÂä°‰∏≠ÂèñÂæó‰∫ÜÂÖ∑ÊúâÁ´û‰∫âÂäõÁöÑÊÄßËÉΩ„ÄÇÂÖ∑‰ΩìÊÄßËÉΩÊï∞ÊçÆÂíåÂØπÊØîÂü∫Á∫øÂú®ËÆ∫Êñá‰∏≠ËØ¶ÁªÜÁªôÂá∫ÔºåË°®ÊòéKRONOSËÉΩÂ§üÊúâÊïàÊèêÂçáLLMÂú®ËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆÂàÜÊûê‰∏≠ÁöÑ‰∏¥Â∫äÊé®ÁêÜËÉΩÂäõÔºå‰∏∫Á≤æÂáÜÂåªÁñóÊèê‰æõÊõ¥ÂèØÈù†ÁöÑÊäÄÊúØÊîØÊåÅ„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ËØ•Á†îÁ©∂ÊàêÊûúÂèØÂ∫îÁî®‰∫éËÇøÁò§Á≤æÂáÜÂåªÁñóÈ¢ÜÂüüÔºåÈÄöËøáÂàÜÊûêÊÇ£ËÄÖÁöÑËõãÁôΩË¥®ÁªÑÂ≠¶Êï∞ÊçÆÔºåÁªìÂêàÂàÜÂ≠êÁõ∏‰∫í‰ΩúÁî®ÁΩëÁªúÔºåÂÆûÁé∞Êõ¥ÂáÜÁ°ÆÁöÑËØäÊñ≠„ÄÅÈ¢ÑÂêéÂíåÊ≤ªÁñóÂàÜÂ±Ç„ÄÇËØ•ÊäÄÊúØËøòÊúâÊΩúÂäõÊâ©Â±ïÂà∞ÂÖ∂‰ªñÁñæÁóÖÈ¢ÜÂüüÔºå‰æãÂ¶ÇÁ•ûÁªèÈÄÄË°åÊÄßÁñæÁóÖÂíåËá™Ë∫´ÂÖçÁñ´ÊÄßÁñæÁóÖÔºå‰ªéËÄåÊé®Âä®‰∏™‰ΩìÂåñÂåªÁñóÁöÑÂèëÂ±ï„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Proteomics data is essential to pathogenic understanding of a disease phenotype. In cancer, analysis of molecular signatures enables precision medicine through the identification of biological processes that drive individualized tumor progression, therapeutic resistance, and clinical heterogeneity. Recent advances in multimodal large language models (LLMs) have shown remarkable capacity to integrate and reason across heterogeneous data modalities. However, performing multi-modal language modeling for molecular understanding of patient-specific proteomics remains a significant challenge due to two barriers: (1) the lack of instruction-tuning datasets that enable clinical interpretation from proteomics data, and (2) the absence of language modeling architectures designed to capture the rich heterogeneity of molecular data. In this work, we introduce CPTAC-PROTSTRUCT, the first instruction tuning dataset for molecular understanding of oncology, comprising over 400k open-ended examples derived from individualized proteomic profiles curated from the largest national proteomics cancer study (CPTAC). Additionally, we propose KRONOS (Knowledge Representation of patient Omics Networks in Oncology via Structured tuning), a novel graph-LLM framework that leverages molecular interaction topology with proteomics to learn patient-specific graph representations for enhanced clinical reasoning. We show that KRONOS achieves competitive performance across benchmark clinical tasks, including molecular classification, temporal trajectory modeling, and tumor stage prediction from proteomics data. Ultimately, this approach empowers LLMs to understand patient-level pathogenesis, advancing precision medicine through more accurate diagnosis, prognosis, and treatment stratification.

